Trinity Biotech Statistics
NASDAQ: TRIBHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
6.24+0.755 (+13.76%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Trinity Biotech by the numbers
Trinity Biotech has a market capitalization of $5.1 million based on 813.13K shares outstanding. With trailing EPS of $-60.00, Trinity Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.4% below its 50-day average and 55.6% below its 200-day average.
Average daily trading volume is 13.54K shares, or about $84,471 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRIB valuation vs. peer median
| Metric | TRIB | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.07M | $5.41M | -6% |
| Avg. volume | 13.54K | 195.12K | -93% |
Peer median across 8 companies: BMRA, CDIO, VNRX, QCLS, VRAX, IMDX, ICCC, NNNN.
Valuation
- Market cap
- $5.07M
- Price / sales (latest FY)
- 0.08
- EPS (TTM)
- $-60.00
- Shares outstanding
- 813.13K
Price and trading
- Previous close
- 5.49
- Open
- 5.01
- Day range
- 4.54 – 6.24
- 52-week range
- 4.54 – 52.50
- Beta
- —
- Volume
- 13.79K
- Average volume
- 13.54K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 22, 2026
Additional statistics
- Market Cap
- 5.07M
- Forward Pe
- -6.06
- Eps
- -60.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.50
- Week52 Low
- 4.54
- Avg Volume
- 13,537.00
- Shares Outstanding
- 813.13K
- Ma50
- 6.67
- Ma200
- 14.06
- Earnings Date
- Dec 22, 2026
- Pct From52w High
- -88.11%
- Pct From52w Low
- 37.60%